logo-loader

Actelion Ltd.

Receive alerts
Market:
PINK
Market Cap:
-
Price
USD
Change
-
52 weeks high
-
52 weeks low
-

In brief

Actelion Ltd is a Swiss biopharmaceutical holding company that focuses on the discovery, development and commercialization of small molecule drugs. The Company has four approved drugs on the market: Tracleer, an oral dual endothelin receptor antagonist; Veletri, a prostanoid vasodilator; Ventavis, an inhaled formulation of iloprost, and Zavesca, an oral treatment for type 1 Gaucher disease.